AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
What is the value of hiring a financial advisor when you're young? Discover how professional guidance can impact your financial journey.
23,649 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Bitcoin fans have watched a calm stretch emerge around the $60,000 mark. This article breaks down what that steady vi...
NVIDIA’s edge in AI infrastructure goes beyond silicon speed. The real reason Nvidia holds its monopoly is a tightly ...
CVS Health is leveraging its vast network to tap into the GLP-1 weight-loss wave. This explainers-backed piece breaks...
As AI spending surges, a handful of ETFs offer broad, diversified access to the AI boom. Four funds map to the AI sta...
Two veteran reporters clash over OpenAI’s potential IPO. One sees missteps and scope creep; the other argues leaks dr...
Binance’s reported mesh investment could shift who controls stablecoin payment rails, signaling a shift from issuers ...
If the idea of Cathie Wood buying million-dollar stakes catches your eye, you’re not alone. This article breaks down ...
Fermi America slumped 11.5% as it unveiled a $375 million convertible note offering and reported a Q1 with zero reven...
Apple pushes to a fresh all-time high as AI-enabled products and a robust services ecosystem drive growth. The move w...
A new Nasdaq-100 strategy fund began paying weekly Friday distributions, targeting a 40% yield and challenging the tr...
Amazon’s chip initiative is quietly redefining cloud economics. This article breaks down the numbers, the tech stack,...